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OBJECTIVE — Weexaminedseculartrendsinthefrequencydistributionofalbuminuriaand
estimated glomerular ﬁltration rate (eGFR) in subjects with type 2 diabetes in 1982–1988 and
2001–2006, two periods associated with major changes in the management of diabetes.
RESEARCH DESIGN AND METHODS — The cross-sectional study included Pima
Indians 15 years old with type 2 diabetes and measures of serum creatinine and urinary
albumin-to-creatinine ratios (ACR). The continuous probability density distributions of ACR
and eGFR were compared for the two time periods. eGFR was calculated using the Modiﬁcation
of Diet in Renal Disease Study equation.
RESULTS — The overall standardized distribution of ACR shifted toward lower values be-
tween time periods (P  0.001), whereas the standardized distribution of eGFR did not (P 
0.45). In the ﬁrst period, eGFR was 60 ml/min per 1.73 m
2 in 6.5% of the 837 subjects. Of
these, 9.3% had normal ACR, 7.4% had microalbuminuria, and 83.3% had macroalbuminuria.
In the second period, the prevalence of low eGFR was similar (6.6% of the 1,310 subjects).
Among those with low eGFR, normal ACR prevalence doubled to 17.2%, microalbuminuria
prevalencenearlytripledto19.5%,andmacroalbuminuriaprevalencedeclinedto63.2%.Twice
as many subjects in the second period received antihypertensive medicines and 30% more
received hypoglycemic medicines than in the ﬁrst period.
CONCLUSIONS — The distribution of albuminuria changed signiﬁcantly among diabetic
Pima Indians over the past 20 years, as treatment with medicines to control hyperglycemia and
hypertension increased. The distribution of eGFR, however, remained unchanged. Conse-
quently, the frequency of chronic kidney disease characterized by normoalbuminuria and low
eGFR doubled.
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C
hronic kidney disease (CKD), char-
acterized by a low glomerular ﬁltra-
tion rate (GFR) in the absence of
elevated urinary albumin excretion, has
been increasingly identiﬁed as a frequent
ﬁnding among individuals with diabetes
(1–5). Whether this ﬁnding represents
nondiabetic kidney disease, a variant of
diabetic kidney disease, or changes in
treatment is uncertain. In type 1 diabetes,
normoalbuminuricwomenwithlowGFR
were found to have more advanced glo-
merular lesions than normoalbuminuric
women with normal GFR (4). On the
other hand, another study that included
both type 1 and type 2 diabetic subjects
with low GFR reported that the risk of
CKD progression or death was lower in
those with normoalbuminuria than in
those with elevated urinary albumin ex-
cretion (5).
In the present study, we examined
the frequency distribution of albumin-
uria and estimated GFR (eGFR) in Pima
Indians with type 2 diabetes in two time
periods characterized by different ther-
apeutic management of diabetic kidney
disease to determine whether a change
in the distribution occurred and if this
change might be related to changes in
management.
RESEARCH DESIGN AND
METHODS— Since 1965, each indi-
vidual 5 years old who resides in the
Gila River Indian Community in Arizona
has been invited to participate in a re-
search examination approximately every
2 years, regardless of health. These bien-
nial examinations include measurements
of venous plasma glucose concentration
obtained2haftera75-goralglucoseload
and assessment for the complications of
diabetes.Diabeteswasdiagnosedby1985
World Health Organization criteria (6),
and the date of diagnosis was determined
from these research examinations or from
review of clinical records if diabetes was
diagnosedinthecourseofroutinemedical
care.Since1July1982,albuminconcentra-
tion was measured with a nephelometric
immunoassay in urine specimens collected
attheendofthe2-hglucosetolerancetest
(7). Values 6.8 mg/l, the threshold be-
neath which albuminuria cannot be de-
tected by the assay, were assigned the
value of 6.8 mg/l. Urine creatinine con-
centration in the same specimen and se-
rum creatinine were measured by a
modiﬁcation of the Jaffe ´ reaction (8). El-
evated albuminuria was deﬁned by a uri-
nary albumin-to-creatinine ratio (ACR)
30 mg/g. eGFR was determined using
the four-variable Modiﬁcation of Diet in
Renal Disease (MDRD) Study equation
(9) (using the racial classiﬁcation of non-
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of 60 ml/min per 1.73 m
2 was consid-
ered low. BMI was deﬁned as weight in
kilograms divided by the square of height
in meters. Mean arterial pressure (MAP)
was calculated as MAP  2⁄3 diastolic ar-
terial pressure  1⁄3 systolic arterial pres-
sure. HbAl was measured by agar gel
electrophoresis (10) through December
1989, and A1C was measured by high-
performance liquid chromatography (11)
thereafter. The correlation between the
two measures was 0.92, as shown in a
previous study, and a linear regression
formula A1C  0.99  HbAl  1.535
was used to estimate A1C in the 794 sub-
jects in whom HbAl was measured (12).
The study population included subjects
whoresidedinthecommunityatanytime
from 1 July 1982 through 30 June 1988
and from 1 January 2001 through 31 De-
cember 2006, attended research exami-
nations at 15 years of age, and had
diabetes.
Statistical analysis
Populationcharacteristicsarepresented
as means  SD or medians (25th and
75th percentiles). Normally distributed
variables were compared with general
linear models adjusted for age and sex.
Variables with nonnormal distributions
were log transformed before comparison.
Binomial variables were similarly ad-
justed using multiple logistic regression.
The study is a cross-sectional com-
parison of two time periods. The preva-
lence of elevated albuminuria was
computed for the two time periods, using
data from the research examination clos-
est to the midpoint of each period. Like-
wise, the prevalence of antihypertensive
and hypoglycemic treatments was com-
puted for the two time periods as the pro-
portion of subjects who were receiving
these medicines at the research examina-
tion closest to the midpoint of these peri-
ods. Treatment was assessed from self-
report of subjects at each research
examination. Complete data on speciﬁc
classes of antihypertensive medicines
wereavailablebeginninginApril1992,so
the proportion treated with renin-
angiotensinsystem(RAS)(ACEinhibitors
and angiotensin receptor antagonists) in-
hibitors was computed for the late period
only. Treatment with RAS inhibitors was
introduced in the Gila River Indian Com-
munityinNovember1986,withonlylim-
ited use until September 1989, so the use
ofthesedrugsduringtheearlyperiodwas
extremely limited.
The continuous probability density
distributions of ACR and eGFR were esti-
mated for each time period; ACR distri-
butions were also estimated for subjects
with normal or low eGFR in each time
period. To account for changes in the un-
derlyingdistributionofconfoundingvari-
ables between the two time periods, ACR
and eGFR from the late time period were
standardized to those of the early period
by indirect adjustment for the three-way
categorizations of age, sex, and diabetes
duration. A total of 20 strata were used
(age  sex  diabetes duration: 2  2 
5) in the adjustment. The standardized
eGFR and logarithmic ACR distributions
in the two time periods were then com-
pared using the Kolmogorov-Smirnov
test. Smoothed distributions were esti-
matedusingSASprockde.Densityvalues
of ACR correspond to the density of the
distribution of the logarithm of ACR. For
clarity, values of untransformed ACR are
shown on a logarithmic scale, which has
an identical relative distribution.
RESULTS— Clinical and demographic
characteristics of the diabetic subjects in
the two time periods are presented in Ta-
ble 1. More subjects received hypoglyce-
mic and antihypertensive medicines in
the late time period (54.4 and 51.1%, re-
spectively) than in the early period (42.0
and 19.8%, respectively). Although sub-
jects in the late period had longer mean
durationofdiabetesandhighermeanBMI
than those included in the early period,
their fasting plasma glucose, MAP, and
ACR were signiﬁcantly lower. A total of
223 subjects were included in both time
periods.
In the early period, 6.5% (n  54) of
the 837 subjects with type 2 diabetes had
eGFR 60 ml/min per 1.73 m
2. Of these,
9.3%(n5)hadnormalACR,7.4%(n
4) had microalbuminuria, and 83.3%
(n  45) had macroalbuminuria. Among
the 1,310 diabetic subjects in the late pe-
riod,theprevalenceofloweGFRwassim-
ilar: 6.6% (n  87). Among those with
low eGFR, the prevalence of normal ACR
had nearly doubled to 17.2% (n  15),
the prevalence of microalbuminuria had
nearly tripled to 19.5% (n  17), and the
prevalence of macroalbuminuria had de-
clined to 63.2% (n  55). The age- and
sex-adjusted logarithm of the average
ACR level changed signiﬁcantly over time
inthestudypopulation(P0.01)(Table
1), more signiﬁcantly in those with low
eGFR (P  0.0003) than in those with
normal eGFR (P  0.02).
Clinical and demographic character-
isticsofthosewitheGFR60ml/minper
1.73 m
2 and elevated or normal ACR in
the two time periods are presented in Ta-
ble 2. Subjects with elevated ACR in the
late period had higher BMI but lower
Table 1—Clinical and demographic characteristics of Pima Indians with diabetes in two time
periods
1982–1988 2001–2006 P*
n 837 1,310
Women 295 474
Men 542 836
Age (years) 46.4  14.5 44.2  13.4 0.0005†
Diabetes duration (years)‡ 7.4 (2.0–14.8) 7.6 (2.0–15.0) 0.04
BMI (kg/m²) 32.9  7.2 37.0  8.9 0.0001
Fasting plasma glucose (mmol/l) 11.3  4.5 9.8  4.3 0.0001
A1C (%) 8.3  2.6 8.4  2.4 0.3
MAP (mmHg) 93.0  13.1 91.3  12.5 0.01
eGFR (ml/min per 1.73 m²) 115.3  35.6 116.8  38.1 0.2
Serum creatinine (mol/l) 72.4  45.0 71.2  35.4 0.9
ACR (mg/g)‡ 27.6 (12.8–159.7) 22.0 (10.3–95.1) 0.01
CKD (%) 47.9 43.6 0.2
Antihypertensive medicines (%) 19.8 51.1 0.0001
RAS inhibitors (%) — 41.3
Hypoglycemic medicines (%) 42.0 54.4 0.0001
Data are unadjusted means  SD or median (25th–75th percentile). CKD is deﬁned as eGFR 60 ml/min
per 1.73 m² or ACR 30 mg/g. In the early time period, data were missing for BMI in 7 subjects, for fasting
plasmaglucosein57subjects,forA1Cin40subjects,andforMAPin5subjects.Inthelateperiod,datawere
missing for BMI in 28 subjects, for fasting plasma glucose in 22 subjects, for A1C in 1 subject, and for MAP
in 9 subjects. *P values were adjusted for age and sex, unless otherwise indicated. †Adjusted for sex.
‡Median.
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period. All but two of the subjects with
low eGFR and normal ACR were women.
Those with normal ACR in the late period
had longer duration of diabetes than sub-
jectsintheearlyperiod.Moreover,90%
of the subjects in the late period received
antihypertensive medicines (n  67 with
elevated ACR and n  14 with normal
ACR),andtwo-thirdsofthemweretaking
RAS inhibitors. They were also twice as
likely to take hypoglycemic medicines as
in the earlier time period, although the
total number of subjects was quite small.
Table 3 shows unstandardized and
standardized prevalence of eGFR and al-
buminuria categories in diabetic Pima In-
dians in the two time periods. Signiﬁcant
changes in the overall age-, sex-, and dia-
betes duration–standardized distribution
of ACR occurred between time periods
(P  0.001) (Fig. 1). These changes were
present in subjects with both normal
eGFR (P  0.002) and low eGFR (P 
0.001) (Fig. 2). In the low eGFR group,
the distributional change reﬂects the in-
crease in the frequency of normal ACR.
No signiﬁcant changes in the standard-
izeddistributionofeGFR(P0.45)(Fig.
1)ortheadjustedprevalenceofloweGFR
occurred between time periods (P 
0.42).
CONCLUSIONS— The frequency
distribution of albuminuria among dia-
betic Pima Indians has changed signiﬁ-
cantly over the past 20 years. The
redistribution of ACR toward lower val-
ues without a concomitant change in
eGFRhasledtoanincreaseinthepropor-
tion of those with CKD characterized by
low eGFR and normoalbuminuria, a con-
dition virtually nonexistent in diabetic
Pima Indians in the 1980s. We are un-
aware of other studies that systematically
examined time trends in the distribution
of ACR and eGFR in a population with
type2diabetes.Thedoublingintheprev-
alence of this condition over the past two
decades coincides with the introduction
and widespread use of more effective
medicines to manage hyperglycemia and
blood pressure in this community (13)
and elsewhere. Although a causal rela-
tionship cannot be determined from an
observational study, these results suggest
that the ﬁnding of low eGFR and normal
urinary albumin excretion in patients
withtype2diabetesisdue,atleastinpart,
to recent improvements in therapeutic
managementofdiabetesanddiabetickid-
ney disease rather than the emergence or
recognitionofanatypicalformofdiabetic
kidney disease, as some have suggested
(1,14,15). Despite the increase in the
prevalence of normoalbuminuria in dia-
betic Pima Indians with low eGFR, the
proportionofsubjectswiththiscondition
remains low at about 1.2% of the diabetic
population.
In the more recent time period, the
Table3—PrevalenceofeGFRandalbuminuriacategoriesindiabeticPimaIndiansintwotime
periods
1982–1988 2001–2006
2001–2006
Standardized
Normal eGFR and normal ACR 436 (52.1) 739 (56.4) 57.7
Normal eGFR and elevated ACR 347 (41.5) 484 (36.9) 36.6
Low eGFR and normal ACR 5 (0.6) 15 (1.1) 1.1
Low eGFR and elevated ACR 49 (5.9) 72 (5.5) 4.6
Dataaren(%)or%.Resultsfor2001–2006arepresentedbothunstandardizedandstandardizedtotheearly
periodafteradjustmentforage,sex,anddurationofdiabetes.NormaleGFR,eGFR60ml/minper1.73m²,
low eGFR, eGFR 60 ml/min per 1.73 m²; normal ACR, ACR 30 mg/g; elevated ACR, ACR 30 mg/g.
Table 2—Clinical and demographic characteristics of diabetic Pima Indians with eGFR <60 ml/min per 1.73 m² and normal or elevated ACR
in two time periods
Elevated ACR Normal ACR
1982–1988 2001–2006 P* 1982–1988 2001–2006 P*
n 49 72 5 15
Men 10 18 1 1
Women 39 54 4 14
Age (years) 60.0 (36.0–79.9) 56.7 (31.4–82.4) 0.1† 69.2 (50.0–84.9) 59.2 (44.2–75.8) 0.1†
Diabetes duration (years)‡ 19.5 (0–37.4) 23.3 (3.2–39.6) 0.2 8.9 (0–19.6) 18.7 (6.6–35.7) 0.04
BMI (kg/m²) 29.0 (18.9–44.1) 33.9 (20.7–70.3) 0.003 28.8 (24.2–32.5) 40.1 (22.8–64.6) 0.1
Fasting plasma glucose
(mmol/l) 9.3 (3.8–26.1) 8.7 (2.8–24.9) 0.4 9.4 (6.2–17.0) 7.9 (4.4–17.8) 0.3
A1C (%) 8.0 (4.0–13.5) 8.0 (5.1–13.1) 0.9 7.6 (5.5–12.1) 8.2 (5.5–13.1) 0.9
MAP (mmHg) 102.6 (69.3–150.0) 97.5 (62.0–135.3) 0.02 91.1 (80.0–97.3) 80.7 (56.0–94.0) 0.1
eGFR (ml/min/1.73 m²) 36.6 (5.4–58.9) 38.3 (10.9–60.0) 0.4 47.9 (35.2–56.7) 43.7 (21.7–57.5) 0.4
Serum creatinine (mol/l) 191.4 (97.2–760.2) 173.9 (94.6–530.4) 0.1 122.0 (97.2–168.0) 133.2 (96.4–221.0) 0.4
ACR (mg/g)‡ 3,943.6 (49.6–46,971.4) 1,944.7 (32.5–20,728.6) 0.001 20.0 (13.1–29.6) 12.1 (5.4–29.4) 0.2
Antihypertensive medicines
(%) 64.6 93.1 0.0003 40.0 93.3 0.06
RAS inhibitors (%) — 76.4 — 66.7
Hypoglycemic medicines (%) 85.1 81.9 0.7 40.0 86.7 0.07
Data are unadjusted means or median (25th–75th percentile). In subjects with elevated ACR, data were missing for BMI in three subjects in the early time period
and in six subjects in the late period; for fasting plasma glucose in three subjects in the early period and ﬁve subjects in the late period; for A1C in three subjects in
the early period, and for MAP in one subject in the late time period. In subjects with normal ACR, data were missing for fasting plasma glucose in one subject in the
late time period. *P values adjusted for age and sex, unless otherwise indicated. †Adjusted for sex. ‡Median.
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diabetic Pima Indians with low eGFR was
17.2%, consistent with studies in other
diabetic populations from the same time
period in which prevalence estimates
rangedbetween13and42%(1–5,14,16),
but twice that of 9.3% found in the Pima
Indiansinthe1980s.Atherosclerosismay
contribute to the appearance of low eGFR
and normoalbuminuria in some diabetic
populations (15), but in diabetic Pima In-
dians, clinical atherosclerosis generally
occurs only after the onset of proteinuric
CKDandhenceisanunlikelyexplanation
for normoalbuminuric CKD in this pop-
ulation (17). On the other hand, im-
proved therapeutic management of
diabetes may be a major contributing fac-
tor to the appearance of normoalbumin-
uria among diabetic patients with low
eGFR in these diabetic populations. In-
deed, studies in which diabetic patients
takingRASinhibitorswereexcludedfrom
the analysis showed a signiﬁcant reduc-
tionintheprevalenceofnormalalbumin-
uriaamongthosewithloweGFR(3,5).To
our knowledge, no one has examined the
role of improved management of hyper-
glycemia on the appearance of nor-
moalbuminuria among diabetic patients
with low eGFR, yet there is abundant ev-
idence that improvements in glycemic
control reduce the frequency of elevated
albuminuria in both types of diabetes
(18–20). The extent to which RAS inhib-
itors and improved glycemic manage-
ment contribute to the shift in ACR
distribution, however, cannot be deter-
mined in this observational study.
We do not have morphological data
from kidney biopsies in Pima Indians
withCKDcharacterizedbyloweGFRand
normal urinary albumin excretion. Nev-
ertheless, postmortem histological exam-
inations of the kidneys in diabetic and
nondiabetic Pima Indians and morpho-
logical studies of kidney biopsies in Pima
Indians with type 2 diabetes reveal that
intercapillary glomerulosclerosis is by far
the predominant form of kidney disease
among diabetic Pima Indians (21). The
extent to which the course of kidney dis-
ease in Pima Indians with low eGFR and
normal urinary albumin excretion differs
from that in Pima Indians with elevated
urinary albumin excretion is not known.
Inthepresentstudy,onlyonepersonwith
CKD characterized by low eGFR and nor-
moalbuminuriaprogressedtokidneyfail-
ure, and this person developed elevated
urinary albumin excretion as the disease
progressed.
Because Pima Indians with diabetes
oftenhavesubstantiallyelevatedGFRin
the early years after diagnosis (22), a
GFR 60 ml/min per 1.73 m
2 may rep-
resent a more signiﬁcant loss of kidney
function than in Caucasian populations
with similar levels of CKD. With the use
Figure 1—Overall change in the continuous distribution of ACR (P  0.001) (A) and the absence of change in the distribution of eGFR (P  0.45)
(B) between time periods. The distributions in the later period, illustrated by the solid line (n  1,310), are age-, sex-, and diabetes duration–
standardized to the early period, illustrated by the dashed line (n  837).
Figure2—OverallchangesinthecontinuousdistributionofACRbetweentimeperiodsinsubjectswithnormaleGFR60ml/minper1.73m
2(P
0.002) (A) and low eGFR 60 ml/min per 1.73 m
2 (P  0.001) (B). In the low-eGFR group, the distributional change reﬂects the increase in the
frequencyofnormalACR.Thedistributionsinthelaterperiod,illustratedbythesolidline,areage-,sex-,anddiabetesduration–standardizedtothe
early period, illustrated by the dashed line. The vertical line in the graphs corresponds to ACR  30 mg/g. N  number of subjects.
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2 to deﬁne low
eGFR instead of 60 ml/min per 1.73 m
2,
20.5% of the diabetic subjects had low
eGFR in the early period and 20.2% in
the late period, with a higher propor-
tion of subjects with low eGFR having
normal ACR in the late period (39.0%)
thanintheearlyperiod(26.7%).Bythis
deﬁnition of CKD, the overall change in
the standardized distribution of ACR
between time periods remained signiﬁ-
cant in subjects with normal or low
eGFR (for the normal eGFR group: P 
0.02; for the low eGFR group: P 
0.0001). At higher GFR, however, the
MDRD equation estimates are more bi-
ased (underestimating measured GFR
for eGFR between 60 and 119 ml/min
per 1.73 m
2 and overestimating mea-
sured GFR for eGFR 120 ml/min per
1.73 m
2) and less precise on both an
absolute and percentage basis, particu-
larly so among populations not in-
cluded in the MDRD study, such as
Pima Indians (23).
A total of 223 individuals were exam-
ined in both time periods. Because the
lack of independence of these observa-
tions could affect the results, we repeated
the analyses after randomly assigning
each of these 223 individuals to only one
of the time periods. By this approach, the
differences between the ACR distribu-
tions in the two time periods were even
greater and the conclusions of the study
were unchanged (data not shown).
In summary, the distribution of al-
buminuria changed signiﬁcantly among
diabetic Pima Indians over the past 20
years without a concomitant change in
thedistributionofeGFR.Asaresult,the
frequency of CKD characterized by nor-
moalbuminuria and low eGFR in dia-
betic Pima Indians doubled and is now
consistent with reports in other popula-
tions from the same time period. The
frequency of low eGFR with normoalbu-
minuria increased signiﬁcantly during a
time when effective treatments for diabe-
tesanddiabetickidneydisease,whichare
known to lower albuminuria, were intro-
duced, suggesting that improvements in
therapeutic management are responsible,
at least in part, for the emergence of this
condition. Whether the clinical course in
these patients differs from that in persons
with more typical diabetic CKD charac-
terized by elevated albuminuria is uncer-
tain, but studies in Pima Indians suggest
that newer treatments for diabetic kidney
disease, while not preventing the devel-
opment of kidney disease, may slow its
progression and reduce the incidence of
end-stage renal disease (24).
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